In celebration of World Nature Conservation Day, MIA is proud to announce our partnership with Enzolytics, the company developing the cure for HIV/AIDS, to help commercialize treatments for multiple animal infectious diseases. Enzolytics develops broadly-neutralizing, species-specific monoclonal antibodies targeting immutable sites on viruses. Samsung Biologics manufactures the company´s primary anti-HIV monoclonal antibody which demonstrated complete efficacy during in vitro testing.
Enzolytics has leveraged its artificial intelligence (A.I.) driven biotechnology platform for infectious disease therapeutics to identify immutable sites on multiple animal viruses. In preparation for the production of monoclonal antibodies used in treatment, Enzolytics has identified immutable sites on the viruses causing each of the following animal infectious diseases:
Accelerate the development of the cure for HIV/AIDS and multiple animal infectious diseases when you make a purchase from our upcoming collection of giclee prints and merchandise in support of Enzolytics